Janney Montgomery Scott LLC lifted its position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 210.5% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 64,191 shares of the medical instruments supplier's stock after buying an additional 43,516 shares during the quarter. Janney Montgomery Scott LLC's holdings in DENTSPLY SIRONA were worth $959,000 at the end of the most recent reporting period.
Several other hedge funds have also recently bought and sold shares of the company. Hanson & Doremus Investment Management purchased a new stake in DENTSPLY SIRONA during the first quarter worth about $90,000. Sound Income Strategies LLC increased its stake in DENTSPLY SIRONA by 43.7% during the 1st quarter. Sound Income Strategies LLC now owns 347,841 shares of the medical instruments supplier's stock worth $5,197,000 after buying an additional 105,777 shares during the period. Wealth Enhancement Advisory Services LLC lifted its holdings in DENTSPLY SIRONA by 39.0% during the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 53,903 shares of the medical instruments supplier's stock worth $805,000 after buying an additional 15,117 shares in the last quarter. Pallas Capital Advisors LLC boosted its holdings in DENTSPLY SIRONA by 222.5% in the first quarter. Pallas Capital Advisors LLC now owns 44,865 shares of the medical instruments supplier's stock valued at $670,000 after purchasing an additional 30,953 shares during the period. Finally, Merit Financial Group LLC purchased a new stake in DENTSPLY SIRONA during the 1st quarter worth about $548,000. Institutional investors and hedge funds own 95.70% of the company's stock.
Wall Street Analyst Weigh In
A number of analysts have weighed in on XRAY shares. Needham & Company LLC restated a "hold" rating on shares of DENTSPLY SIRONA in a research note on Thursday, March 13th. Wall Street Zen raised shares of DENTSPLY SIRONA from a "hold" rating to a "buy" rating in a research report on Friday, May 9th. Mizuho dropped their price objective on DENTSPLY SIRONA from $21.00 to $18.00 and set a "neutral" rating on the stock in a report on Thursday, March 13th. UBS Group reduced their target price on DENTSPLY SIRONA from $27.00 to $25.00 and set a "buy" rating for the company in a report on Friday, May 9th. Finally, Piper Sandler decreased their target price on DENTSPLY SIRONA from $20.00 to $16.00 and set a "neutral" rating for the company in a research report on Wednesday, April 30th. Eleven analysts have rated the stock with a hold rating and three have given a buy rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Hold" and an average price target of $20.36.
Check Out Our Latest Analysis on DENTSPLY SIRONA
DENTSPLY SIRONA Stock Performance
DENTSPLY SIRONA stock traded down $0.04 during trading hours on Thursday, reaching $16.54. 1,623,756 shares of the stock were exchanged, compared to its average volume of 2,930,827. DENTSPLY SIRONA Inc. has a 52-week low of $12.16 and a 52-week high of $27.95. The stock has a market cap of $3.30 billion, a P/E ratio of -3.64, a P/E/G ratio of 1.18 and a beta of 0.94. The company has a debt-to-equity ratio of 0.79, a quick ratio of 0.76 and a current ratio of 1.10. The firm's 50 day moving average is $15.59 and its 200 day moving average is $16.52.
DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last posted its quarterly earnings results on Thursday, May 8th. The medical instruments supplier reported $0.43 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.29 by $0.14. DENTSPLY SIRONA had a negative net margin of 24.42% and a positive return on equity of 14.31%. The firm had revenue of $879.00 million during the quarter, compared to analysts' expectations of $854.75 million. During the same period in the prior year, the company posted $0.42 earnings per share. The firm's revenue for the quarter was down 7.8% on a year-over-year basis. Analysts predict that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current fiscal year.
DENTSPLY SIRONA Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, July 11th. Investors of record on Friday, June 27th will be paid a $0.16 dividend. The ex-dividend date is Friday, June 27th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 3.87%. DENTSPLY SIRONA's dividend payout ratio (DPR) is presently -14.10%.
About DENTSPLY SIRONA
(
Free Report)
DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.
Featured Articles

Before you consider DENTSPLY SIRONA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DENTSPLY SIRONA wasn't on the list.
While DENTSPLY SIRONA currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.